Mingke Cui

OLR1 is a prognostic factor and correlated with immune infiltration in breast cancer

Xiangyu Sun, Xin Fu, Shouping Xu et al. · International Immunopharmacology · 2021 · 59 citations

Medicine, Immunology, Oncology +16

Upregulation of PITX2 Promotes Letrozole Resistance Via Transcriptional Activation of IFITM1 Signaling in Breast Cancer Cells

Yingying Xu, Hairu Yu, Jiayi Sun et al. · Cancer Research and Treatment · 2018 · 23 citations · Full text

Life Sciences, Cancer Biology, Oncology +17

Efficacy, safety and exploratory analysis of neoadjuvant tislelizumab (a PD-1 inhibitor) plus nab-paclitaxel followed by epirubicin/cyclophosphamide for triple-negative breast cancer: a phase 2 TREND trial

Qiang Zhang, Mozhi Wang, Yumeng Li et al. · Signal Transduction and Targeted Therapy · 2025 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

Leptin-elicited PBX3 confers letrozole resistance in breast cancer

Zhiyuan Pang, Mu-Yan Shang, Shuang Li et al. · Endocrine Related Cancer · 2021 · 17 citations

Medicine, Molecular Biology, Oncology +17

A machine learning model to predict efficacy of neoadjuvant therapy in breast cancer based on dynamic changes in systemic immunity

Yusong Wang, Mozhi Wang, Ke‐Da Yu et al. · Cancer Biology and Medicine · 2023 · 15 citations · Full text

Life Sciences, Immunology, Oncology +17